Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|January 15, 2017
Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agentsRania Hamdy, Noha I Ziedan, Samia Ali, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|November 14, 2015
Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterizationBrittany Haynes, Yanhua Zhang, Fangchao Liu, et al.Biochemical and Biophysical Research Communications|June 8, 2006
Antitumor quinols: role of glutathione in modulating quinol-induced apoptosis and identification of putative cellular protein targetsEng-Hui Chew, Charles S Matthews, Jihong Zhang, et al.ACS Infectious Diseases|May 16, 2019
Antischistosomal Properties of Sclareol and Its Heck-Coupled Derivatives: Design, Synthesis, Biological Evaluation, and Untargeted MetabolomicsAlessandra Crusco, Helen Whiteland, Rafael Baptista, et al.Journal of Medicinal Chemistry|January 22, 2005
Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agentsJane M Berry, Tracey D Bradshaw, Iduna Fichtner, et al.Bioorganic & Medicinal Chemistry Letters|October 25, 2013
Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamidesHend Kothayer, Abdalla A Elshanawani, Mansour E Abu Kull, et al.International Journal of Molecular Sciences|November 27, 2021
New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer AgentsRania Hamdy, Arwyn T Jones, Mohamed El-Sadek, et al.Journal of Medicinal Chemistry|August 1, 2008
Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)Stefania Aiello, Geoffrey Wells, Erica L Stone, et al.Chemmedchem|September 18, 2025
Next-Generation Bcl-2 Inhibitors: Design and Evaluation of Indolyl-Triazole Derivatives with Anticancer PotentialAhmed M Almehdi, Samar Damiati, Ihsan A Shehadi, et al.Cancer Research|May 4, 2005
Elucidation of thioredoxin as a molecular target for antitumor quinolsTracey D Bradshaw, Charles S Matthews, Jennifer Cookson, et al.Pageof 9